Literature DB >> 24684355

Cystic fibrosis transmembrane conductance regulator and pseudomonas.

Edith T Zemanick1, Frank J Accurso.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24684355      PMCID： PMC4225835          DOI： 10.1164/rccm.201402-0209ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  Evidence for airway surface dehydration as the initiating event in CF airway disease.

Authors:  R C Boucher
Journal:  J Intern Med       Date:  2007-01       Impact factor: 8.989

2.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

Authors:  Michael W Konstan; Wayne J Morgan; Steven M Butler; David J Pasta; Marcia L Craib; Stefanie J Silva; Dennis C Stokes; Mary Ellen B Wohl; Jeffrey S Wagener; Warren E Regelmann; Charles A Johnson
Journal:  J Pediatr       Date:  2007-06-22       Impact factor: 4.406

3.  Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.

Authors:  Margaret Rosenfeld; Julia Emerson; Sharon McNamara; Valeria Thompson; Bonnie W Ramsey; Wayne Morgan; Ronald L Gibson
Journal:  J Cyst Fibros       Date:  2012-05-01       Impact factor: 5.482

Review 4.  Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.

Authors:  G B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 5.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

6.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

Review 7.  Non-cystic fibrosis bronchiectasis.

Authors:  Pamela J McShane; Edward T Naureckas; Gregory Tino; Mary E Strek
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

8.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

Review 9.  Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

Authors:  Gerd Döring; Patrick Flume; Harry Heijerman; J Stuart Elborn
Journal:  J Cyst Fibros       Date:  2012-11-06       Impact factor: 5.482

10.  Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.

Authors:  Morten Alhede; Kasper Nørskov Kragh; Klaus Qvortrup; Marie Allesen-Holm; Maria van Gennip; Louise D Christensen; Peter Østrup Jensen; Anne K Nielsen; Matt Parsek; Dan Wozniak; Søren Molin; Tim Tolker-Nielsen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240
View more
  1 in total

1.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Mary J Emond; Tin Louie; Julia Emerson; Jessica X Chong; Rasika A Mathias; Michael R Knowles; Mark J Rieder; Holly K Tabor; Debbie A Nickerson; Kathleen C Barnes; Lung Go; Ronald L Gibson; Michael J Bamshad
Journal:  PLoS Genet       Date:  2015-06-05       Impact factor: 5.917
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.